What is proximal dvt




















Am Fam Physician ; Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest ; Piovella F, et al.

Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Haematologica ; Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med ; The clinical course of deep-vein thrombosis. Prospective long-term follow-up of symptomatic patients. The long-term clinical course of acute deep venous thrombosis.

Ann Intern Med ; A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med ; Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial.

JAMA ; Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis the CaVenT study : a randomised controlled trial. Lancet ; Comerota AJ. Quality-of-life improvement using thrombolytic therapy for iliofemoral deep venous thrombosis.

Rev Cardiovasc Med ;3 Suppl 2:S Siegel RJ, Luo H. Ultrasound thrombolysis Ultrasonics ; Pulmonary embolism from pulse-spray pharmacomechanical thrombolysis of clotted hemodialysis grafts: urokinase versus heparinized saline. Mechanical versus chemical thrombolysis: an in vitro differentiation of thrombolytic mechanisms.

J Vasc Interv Radiol ;11 2 Pt 1 Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. Park C, So BJ. Vasc Specialist Int ; Sharifi M, et al. Catheter Cardiovasc Interv ; Prandoni P.

Risk factors of recurrent venous thromboembolism: the role of residual vein thrombosis. Pathophysiol Haemost Thromb ; Akesson H, et al. Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg ; Three principle types of PMT device are in use rotational, rheolytic and ultrasound enhanced devices and are combined with CDT in pharmocomechanical thrombolysis PhMT to enhance early thrombus removal.

These devices have individual device specific attributes and side effects that are additional to the bleeding complications of thrombolysis. IVC filter deployment to reduce periprocedural PE, is supported by little evidence unless an indication for its use already exists. COVID and venous thromboembolism: a meta-analysis of literature studies. Semin Thromb Hemost. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.

Anticoagulant therapy for symptomatic calf deep vein thrombosis CACTUS : a randomised, double-blind, placebo-controlled trial. Robert-Ebadi H, Righini M. Management of distal deep vein thrombosis. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Dalteparin versus unfractionated heparin in critically ill patients.

N Engl J Med. Comparative performance of clinical risk assessment models for hospital-acquired venous thromboembolism in medical patients. Anticoagulant interventions in hospitalized patients with COVID a scoping review of randomized controlled trials and call for international collaboration. Download references. The authors thank Mafalda Burri for her contribution to the search strategy.

You can also search for this author in PubMed Google Scholar. All authors designed the study. GL and MB conducted the analyses. GL drafted the manuscript. All authors critically revised the manuscript and accepted the final version of the manuscript.

Correspondence to Marc Blondon. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Search strategies.

Table S1. Table S2. Newcastle-Ottawa scale for included cohort studies. Table S3. Detailed characteristics of included studies. Table S4. Detailed characteristics of participants.

Table S5. VTE stratified by the type of anticoagulation none, prophylactic, therapeutic. Figure S1. Figure S2. Forrest plot of the estimated incidence of proximal DVT:2a stratified by medical ward and ICU;2b stratified by location and screening.

Figure S3. Forrest plot of the estimated incidence of PE:3a stratified by general ward and ICU;3b stratified by location and screening. Figure S4. Figure S5. Sensitivity analysis, restricting to high-quality studies:5a stratified by location; b stratified by location and screening.

The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. Reprints and Permissions. Longchamp, G. Proximal deep vein thrombosis and pulmonary embolism in COVID patients: a systematic review and meta-analysis.

Thrombosis J 19, 15 Download citation. Received : 03 November Accepted : 01 March Published : 09 March Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Skip to main content. Search all BMC articles Search.

Download PDF. Statistical analysis The primary analysis estimated the risk of major VTE among studies including all inpatients — general medical wards and critical care units — and among studies including only intensive care unit ICU patients. Results Study selection and characteristics Electronic database searches identified titles and abstracts Fig. Full size image. Table 1 Characteristics of included studies Full size table. Table 3 Meta-analytic estimates of the risk of VTE, stratified by location and screening Full size table.



0コメント

  • 1000 / 1000